[Pe-066] English Poster Session 066「Neuroimmunology: Basic research 2」

[Pe-066-6] Exosome SNORD37 is a new marker for relapse mitigation in NMO and miR133b is that for progressive MS

Maimaitijiang Guzailiayi¹, Jun-ichi Kira^1,2,3, Ayako Sakoda^1,2, Mitsuru Watanabe⁴, Satoshi Nagata⁴, Ezgi Ozdemir⁴, Katsuhisa Masaki⁴, Ryo Yamasaki⁴, Noriko Isobe⁴, Xu Zhang¹, Tomohiro Imamura^1,3, Yuri Nakamura^1,2,3 (1.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Okawa, Japan, 2.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan, Japan, 3.School of Pharmacy at Fukuoka, International University of Health and Welfare, Okawa, Japan, Japan, 4.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Japan)